Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers A pooled analysis of randomized trials

被引:8
作者
Bryant, Kristina A. [1 ]
McVernon, Jodie [2 ,3 ]
Marchant, Colin D. [4 ]
Nolan, Terry [2 ,3 ]
Marshall, Gary S. [1 ]
Richmond, Peter [5 ,6 ]
Marshall, Helen [7 ,8 ]
Nissen, Michael [9 ,10 ]
Lambert, Stephen B. [9 ,10 ]
Aris, Emmanuel [11 ]
Mesaros, Narcisa [11 ]
Miller, Jacqueline M. [12 ]
机构
[1] Univ Louisville, Louisville, KY 40292 USA
[2] Murdoch Childrens Res Inst, Vaccine & Immunisat Res Grp, Melbourne, Vic, Australia
[3] Univ Melbourne, Melbourne, Vic, Australia
[4] Boston Univ, Med Ctr, Boston, MA USA
[5] Univ Western Australia, Sch Paediat & Child Hlth, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia
[6] Princess Margaret Hosp Children, Perth, WA, Australia
[7] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia
[8] Womens & Childrens Hosp, Vaccinol & Immunol Res Trials Unit, Adelaide, SA, Australia
[9] Univ Queensland, Brisbane, Qld, Australia
[10] Royal Childrens Hosp, Queensland Childrens Med Res Inst, Queensland Paediat Infect Dis Lab, Brisbane, Qld, Australia
[11] GlaxoSmithKline Biol, Wavre, Belgium
[12] GlaxoSmithKline Biol, King Of Prussia, PA USA
关键词
Haemophilus influenzae type b; Neisseria meningitidis serogroups C and Y; MMR; varicella; vaccination; toddlers; INFANTS; PERSISTENCE; HIBMENCY; ANTIBODY; AGE;
D O I
10.4161/hv.20357
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A pooled analysis was conducted of 1,257 toddlers who received a fourth dose of Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY-TT) or Hib conjugate vaccine (Hib polysaccharide conjugated to N. meningitidis outer membrane protein) coadministered with measles-mumps-rubella (MMR) and varicella (VAR) vaccines (NCT00134719/NCT00289783). Noninferiority of immunological responses to MMR and VAR was demonstrated between groups and incidences of MMR- and VAR-specific solicited symptoms were similar, indicating that HibMenCY-TT can be coadministered with MMR and VAR.
引用
收藏
页码:1036 / 1041
页数:6
相关论文
共 10 条
[1]  
Advisory Committee on Immunization Practices, 2011, CHILD AD IMM SCHED
[2]  
[Anonymous], 2009, ACTHIB PACK INS
[3]   Immunogenicity and Safety of H influenzae Type b-N meningitidis C/Y Conjugate Vaccine in Infants [J].
Bryant, Kristina A. ;
Marshall, Gary S. ;
Marchant, Colin D. ;
Pavia-Ruiz, Noris ;
Nolan, Terry ;
Rinderknecht, Stephen ;
Blatter, Mark ;
Aris, Emmanuel ;
Lestrate, Pascal ;
Boutriau, Dominique ;
Friedland, Leonard R. ;
Miller, Jacqueline M. .
PEDIATRICS, 2011, 127 (06) :E1375-E1385
[4]   Combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C (HibMenC) or serogroup C and Y-tetanus toxoid conjugate (and HibMenCY) vaccines are well-tolerated and immunogenic when administered according to the 2, 3, 4 months schedule with a fourth dose at 12-18 months of age [J].
Habermehl, Pirmin ;
Leroux-Roels, Geert ;
Sanger, Roland ;
Machler, Gudrun ;
Boutriau, Dominique .
HUMAN VACCINES, 2010, 6 (08) :640-651
[5]   The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children -: A study of manufacturing consistency and persistence of antibody [J].
Lieberman, Jay M. ;
Williams, Wendy R. ;
Miller, Jacqueline M. ;
Black, Steven ;
Shinefield, Henry ;
Henderson, Frederick ;
Marchant, Colin D. ;
Werzberger, Alan ;
Halperin, Scott ;
Hartzel, Jonathan ;
Klopfer, Stephanie ;
Schodel, Florian ;
Kitter, Barbara J. .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (07) :615-622
[6]   Randomized Trial to Assess Immunogenicity and Safety of Haemophilus influenzae Type b and Neisseria meningitidis Serogroups C and Y-Tetanus Toxoid Conjugate Vaccine in Infants [J].
Marchant, Colin D. ;
Miller, Jacqueline M. ;
Marshall, Gary S. ;
Blatter, Mark ;
Aris, Emmanuel ;
Friedland, Leonard R. ;
Boutriau, Dominique .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (01) :48-52
[7]   IMMUNE RESPONSE AND ONE-YEAR ANTIBODY PERSISTENCE AFTER A FOURTH DOSE OF A NOVEL HAEMOPHILUS INFLUENZAE TYPE B AND NEISSERIA MENINGITIDIS SEROGROUPS C AND Y-TETANUS TOXOID CONJUGATE VACCINE (HIBMENCY) AT 12 TO 15 MONTHS OF AGE [J].
Marshall, Gary S. ;
Marchant, Colin D. ;
Blatter, Mark ;
Aris, Emmanuel ;
Boutriau, Dominique ;
Poolman, Jan T. ;
Friedland, Leonard R. ;
Miller, Jacqueline M. .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (05) :469-471
[8]   A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants [J].
Nolan, Terry ;
Lambert, Stephen ;
Roberton, Don ;
Marshall, Helen ;
Richmond, Peter ;
Streeton, Catherine ;
Poolman, Jan ;
Boutriau, Dominique .
VACCINE, 2007, 25 (51) :8487-8499
[9]   Immunogenicity and Safety of an Investigational Combined Haemophilus influenzae Type B-Neisseria meningitidis Serogroups C and Y-Tetanus Toxoid Conjugate Vaccine [J].
Nolan, Terry ;
Richmond, Peter ;
Marshall, Helen ;
McVernon, Jodie ;
Alexander, Karyn ;
Mesaros, Narcisa ;
Aris, Emmanuel ;
Miller, Jacqueline ;
Poolman, Jan ;
Boutriau, Dominique .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (03) :190-196
[10]   Measles, mumps, rubella vaccine (Priorix™; GSK-MMR) -: A review of its use in the prevention of measles, mumps and rubella [J].
Wellington, K ;
Goa, KL .
DRUGS, 2003, 63 (19) :2107-2126